Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features

Helena Ferreira Leal(Fundação Oswaldo Cruz), Edilane Lins Gouveia, Márcio de Oliveira Silva(D’Or Institute for Research and Education), Giulyana Evelyn Oliveira Silva(Universidade Federal da Bahia), J. Fraga De Azevedó(Fundação Oswaldo Cruz), Larissa Rangel Cabral de Roma(Universidade Federal da Bahia), Ianick Souto Martins(Universidade Federal Fluminense), Mitermayer Galvão dos Reis(Universidade Federal da Bahia), Ana Carolina Palmeira Arraes(Hospital São Rafael), Angelica Maria Lima Amorim(Universidade Federal da Bahia), Maria Goreth Barberino(Hospital São Rafael), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública)
BMC Infectious Diseases
July 11, 2019
10.1186/s12879-019-4265-z
Cited by 91

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
|Biomedicine & Pharmacotherapy|2021|121